EssilorLuxottica Cash on Hand 2011-2024 | ESLOY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

EssilorLuxottica cash on hand for 2024 was $2.436B, a 12.02% decline from 2023.
EssilorLuxottica cash on hand for 2023 was $2.769B, a 34.07% increase from 2022.
EssilorLuxottica cash on hand for 2022 was $2.065B, a 46.99% decline from 2021.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

EssilorLuxottica cash on hand for 2024 was $2.436B, a 12.02% decline from 2023.
EssilorLuxottica cash on hand for 2023 was $2.769B, a 34.07% increase from 2022.
EssilorLuxottica cash on hand for 2022 was $2.065B, a 46.99% decline from 2021.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$219.8B
Boston Scientific (BSX)	$156.6B
Stryker (SYK)	$152.9B
Medtronic (MDT)	$118B
Lonza Group Ag (LZAGY)	$49.3B
Haleon (HLN)	$43.6B
ResMed (RMD)	$40.1B
GE HealthCare Technologies (GEHC)	$35.6B
Agilent Technologies (A)	$34B
Terumo (TRUMY)	$25.6B
Koninklijke Philips (PHG)	$24.7B
Insulet (PODD)	$20.6B
Zimmer Biomet Holdings (ZBH)	$19B
Baxter (BAX)	$14.6B
Smith & Nephew SNATS (SNN)	$13.7B
Sunny Optical Technology (SNPTF)	$10.4B
Demant (WILYY)	$8.6B
Bio-Rad Laboratories (BIO)	$6.9B
Lantheus Holdings (LNTH)	$5B
Perrigo (PRGO)	$3.9B
Prestige Consumer Healthcare (PBH)	$3.8B
Haemonetics (HAE)	$3.6B
Envista Holdings (NVST)	$3.5B
Shandong Weigao Medical Polymer (SHWGF)	$3.5B
ICU Medical (ICUI)	$3.1B
LeMaitre Vascular (LMAT)	$1.9B
QuidelOrtho (QDEL)	$1.8B
AtriCure (ATRC)	$1.6B
Acuren (TIC)	$1.4B
Green Thumb Industries (GTBIF)	$1.3B